Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1969 Mar;23(1):210–226. doi: 10.1038/bjc.1969.30

The selectivity of action of alkylating agents and drug resistance. I. Biochemical changes occurring in sensitive and resistant strains of the Yoshida ascites sarcoma following chemotherapy.

K R Harrap, B T Hill
PMCID: PMC2008306  PMID: 5768437

Full text

PDF
210

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BROWN P. S. Fractionation of human urinary gonadotrophins. Nature. 1956 Aug 11;178(4528):315–316. doi: 10.1038/178315a0. [DOI] [PubMed] [Google Scholar]
  2. Ball C. R., Connors T. A., Double J. A., Ujhazy V., Whisson M. E. Comparison of nitrogen-mustard sensitive and -resistant Yoshida sarcomas. Int J Cancer. 1966 Jul 15;1(4):319–327. doi: 10.1002/ijc.2910010403. [DOI] [PubMed] [Google Scholar]
  3. CONNORS T. A., DOUBLE J. A., ELSON L. A., JENEY A., Jr REDUCTION OF THE TOXICITY OF "RADIOMIMETIC" ALKYLATING AGENTS IN RATS BY THIOL PRE-TREATMENT. IV. PROTECTION AGAINST BONE MARROW DAMAGE. Biochem Pharmacol. 1965 Apr;14:569–577. doi: 10.1016/0006-2952(65)90229-7. [DOI] [PubMed] [Google Scholar]
  4. Crathorn A. R., Roberts J. J. Mechanism of the cytotoxic action of alkylating agents in mammalian cells and evidence for the removal of alkylated groups from deoxyribonucleic acid. Nature. 1966 Jul 9;211(5045):150–153. doi: 10.1038/211150a0. [DOI] [PubMed] [Google Scholar]
  5. HARRAP K. R., SPEED D. E. SOME BIOCHEMICAL ASPECTS OF LEUKAEMIAS: THE APPEARANCE OF A SOLUBLE DISULPHIDE IN THE BLOOD IN CHRONIC GRANULOCYTIC LEUKAEMIA. Br J Cancer. 1964 Dec;18:809–817. doi: 10.1038/bjc.1964.94. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Harrap K. R., Hill B. T. The selectivity of action of alkylating agents and drug resistance. II. A comparison of the effects of alkylating drugs on growth inhibition and cell size in sensitive and resistant strains of the Yoshida ascites sarcoma. Br J Cancer. 1969 Mar;23(1):227–234. doi: 10.1038/bjc.1969.31. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Harrap K. R. The application of 5,5' dithiobis-2-nitrobenzoic acid to the determination of the acid-soluble disulphide content of blood. Biochem Pharmacol. 1967 Apr;16(4):725–731. doi: 10.1016/0006-2952(67)90086-x. [DOI] [PubMed] [Google Scholar]
  8. KUN E., LANGER B., ULRICH B., HOLZER H., GRUNICKE H. THE ROLE OF DPNASE IN THE MECHANISM OF ACTION OF AN ANTITUMOR ALKYLATING AGENT ON EHRLICH ASCITES CELLS. Proc Natl Acad Sci U S A. 1964 Dec;52:1501–1506. doi: 10.1073/pnas.52.6.1501. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Kohn K. W., Steigbigel N. H., Spears C. L. Cross-linking and repair of DNA in sensitive and resistant strains of E. coli treated with nitrogen mustard. Proc Natl Acad Sci U S A. 1965 May;53(5):1154–1161. doi: 10.1073/pnas.53.5.1154. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  11. Lawley P. D., Brookes P. Molecular mechanism of the cytotoxic action of difunctional alkylating agents and of resistance to this action. Nature. 1965 May 1;206(983):480–483. doi: 10.1038/206480a0. [DOI] [PubMed] [Google Scholar]
  12. VOLKIN E., COHN W. E. Estimation of nucleic acids. Methods Biochem Anal. 1954;1:287–305. doi: 10.1002/9780470110171.ch11. [DOI] [PubMed] [Google Scholar]
  13. WALFORD R. L., PETERSON E. T., DOYLE P. Leukocyte antibodies in human sera and in immune rabbit sera. Blood. 1957 Nov;12(11):953–971. [PubMed] [Google Scholar]
  14. WARWICK G. P. THE MECHANISM OF ACTION OF ALKYLATING AGENTS. Cancer Res. 1963 Sep;23:1315–1333. [PubMed] [Google Scholar]
  15. Wade R., Whisson M. E., Szerkerke M. Some serum protein nitrogen mustard complexes with high chemotherapeutic selectivity. Nature. 1967 Sep 16;215(5107):1303–1304. doi: 10.1038/2151303a0. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES